Analgesics
31
2
2
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.7%
3 terminated out of 31 trials
83.3%
-3.2% vs benchmark
32%
10 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (31)
Natural History of Depression, Bipolar Disorder and Suicide Risk
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
Pregabalin vs. Gabapentin on Reducing Opioid Usage
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
Comparison of 2 Different Methods in Infraclavicular Block
U/S Guided Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block vs Type 2 Pectoral Nerve Block
Rescue Quadratus Lumborum Blocks for Post-cesarean Pain
Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion
Opioid-free Anesthesia in Thyroidectomies
Opioid-free Anesthesia in Laparoscopic Cholecystectomies
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Opioid Sparing Anesthesia in Cervical Spine Surgery
Opioid Sparing Anesthesia in Lumbar Spine Surgery
Lidocaine and Magnesium and Ketamine in Gynecological Surgery
Opioid-free Anesthesia With a Mixture of Dexmedetomidine-lidocaine-ketamine
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
Analgesia in ÖAMTC Helicopter Emergency Service in Austria